Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome

British Journal of Dermatology

Volumn 153, Issue 1, 2005, Pages 118-124

  Klemke, Claus Detlev ^a   Mansmann, U ^b   Poenitz, N ^a   Dippel, E ^a   Goerdt, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

CTCL Severity Index; Cutaneous T cell lymphoma; Prediction of prognosis; Prognostic factors; Survival rate formula

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE SEVERITY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOSIS FUNGOIDES; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SCORING SYSTEM; SEZARY SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEZARY SYNDROME; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 22944492427     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06676.x     Document Type: Article

References (29)

1. Weinstock MA, Horm JW. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 1988; 260:42-6.
2. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90:354-71.
3. Bunn PA Jr, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63:725-8.
4. Zackheim HS, Vonderheid EC, Ramsay DL et al. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000; 43:793-6.
5. Kim YH, Jensen RA, Watanabe GL et al. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996; 132:1309-13.
6. Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999; 135:26-32.
7. Kim YH, Bishop K, Varghese A, Hoppe RT. Prognostic factors in erylhrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 1995; 131:1003-8.
8. Dippel E, Goerdt S, Assaf C et al. Cutaneous T-cell lymphoma severity index and T-cell gene rearrangement. Lancet 1997; 350:1776-7.
9. Dippel E, Schrag H, Goerdt S, Orfanos CE. Extracorporeal photopheresis and interferon-α in advanced cutaneous T-cell lymphoma. Lancet 1997; 350:32-3.
10. Dippel E, Assaf C, Hummel M et al. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol 1999; 188:146-54.
11. Assaf C, Hummel M, Dippel E et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000; 96:640-6.
12. Klemke CD, Dippel E, Dembinski A et al. Clonal T cell receptor γ-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides. J Pathol 2002; 197:348-54.
13. Vonderheid EC, Bernengo MG, Burg G et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46:95-106.
14. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer-Verlag, 1997.
15. Graf E, Schmoor C, Sauerbrei W. Assessment and comparison of prognostic classification schemes for survival data, section 5. Stat Med 2000; 18:2529-45.
16. Schemper M, Henderson R. Predictive accuracy and explained variation in Cox regression. Biometrics 2000; 56:249-55.
17. Sausville EA, Worsham GF, Matthews MJ et al. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol 1985; 16:1098-109.
18. Kim YH, Liu HL, Mraz-Gernhard S et al. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003; 139:857-66.
19. Fink-Puches R, Zenahlik P, Back B et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99:800-5.
20. Toro JR, Stoll HL Jr, Stomper PC, Oseroff AR. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 1997; 37:58-67.
21. Sausville EA. T-cell leukemia-lymphoma and mycosis fungoides. Curr Opin Oncol 1992; 4:829-39.
22. Diamandidou E, Colome M, Fayad L et al. Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 1999; 40:914-24.
23. Heald P, Yan SL, Edelson R. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. Arch Dermatol 1994; 130:198-203.
24. Dippel E, Klemke D, Hummel M et al. T-cell clonality of undetermined significance. Blood 2001; 98:247-8.
25. Scarisbrick JJ, Whittaker S, Evans AV et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001; 97:624-30.
26. Marti RM, Pujol RM, Servitje O et al. Sézary syndrome and related variants of classic cutaneous T-cell lymphoma. A descriptive and prognostic clinicopathologic study of 29 cases. Leuk Lymphoma 2003; 44:59-69.
27. Foulc P, N'Guyen JM, Dreno B. Prognostic factors in Sézary syndrome: a study of 28 patients. Br J Dermatol 2003; 149:1152-8.
28. Schmid MH, Bird P, Dummer R et al. Tumor Burden Index as a prognostic tool for cutaneous T-cell lymphoma. Arch Dermatol 1999; 135:1204-8.
29. Stevens SR, Ke MS, Parry EJ et al. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the Severity-Weighted Assessment Tool (SWAT). Arch Dermatol 2002; 138:42-8.